ESH-iCMLf 13th International Conference CHRONIC MYELOID LEUKEMIA - Biology and Therapy
Webcasted Presentation

Search’n Build™

Evaluation of the efficacy and mechanism of action of the JAK2 inhibitor INCB18424 in primary CML stem/progenitor cells

Paolo Gallipoli
Paolo Gallipoli
United Kingdom  
Disclosure : Research funded by Novartis
[More] [Less]
13 slide(s) – 00:08:01 – English – 2011-09-22
Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.